Drug recall · December 9, 2020
Aripiprazole Tablets recall
Why: Failed Dissolution Specifications: Out of specification for dissolution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Aripiprazole Tablets, USP, 15 mg, 30 tablets per unit dose carton, Rx Only, Manufactured by: Apotex, Inc, Toronto, Ontario Canada M9L 1T9, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6512-04
- Lots / codes
Lots: T02520, T02637, exp 02/2021
- Quantity
- 841 cartons
- Company
- The Harvard Drug Group, Livonia, MI
- Distribution
- Nationwide
- Initiated
- November 18, 2020 · Voluntary: Firm initiated
- Classified
- December 1, 2020
- Reported
- December 9, 2020
- Ended
- February 19, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Aripiprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.